Xarelto 20 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FJ5A2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,751
Award facts
- Contract value 100% obligated
- $34,750.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $34,750.69 to AmerisourceBergen Drug Corp for the supply of Xarelto 20 mg tablets (90-count units) under a firm fixed-price arrangement. The award, issued on January 12, 2026, with an ultimate completion date of January 13, 2026, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this delivery order, which will be performed at the company's corporate office location in Conshohocken. The underlying contract vehicle is the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999.9 billion through December 2026, which enables AmerisourceBergen to supply comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving federal agencies including the Defense Health Agency and U.S. Coast Guard. The company's substantial IDC with DLA encompasses a broad portfolio of medications across multiple therapeutic domains, including specialty drugs, brand-name and generic pharmaceuticals, vaccines, and related medical supplies. This delivery order for Xarelto, an anticoagulant medication, exemplifies the company's role as a critical vendor in the federal medical supply chain, fulfilling essential prescription medication requirements for military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FJ5A2?
SPE2DR26FJ5A2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FJ5A2 worth?
The government has obligated $34,751 on SPE2DR26FJ5A2.
Is contract SPE2DR26FJ5A2 an order under another contract?
Yes. SPE2DR26FJ5A2 is a delivery order under SPE2DR25D2009, an indefinite delivery contract.
Was contract SPE2DR26FJ5A2 competed?
The extent of competition for SPE2DR26FJ5A2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award